Veraseal (human fibrinogen;human thrombin)
- Region
- 🇪🇺 EU
- Active substance
- human fibrinogen;human thrombin
- Company
- Instituto Grifols, S.A.
- Status
- Application withdrawn
- Therapeutic area
- Hemostasis, Surgical
- Application
- EMEA/H/C/003914
- ATC
- B02BC
- Official record
- www.ema.europa.eu
Indication
Supportive treatment for improvement of haemostasis and as a suture support in vascular surgery
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 TachoSil Authorised · Corza Medical GmbH
- 🇪🇺 VeraSeal Authorised · Instituto Grifols, S.A.
- 🇪🇺 Evicel Withdrawn · Omrix Biopharmaceuticals N. V.
- 🇪🇺 Raplixa Withdrawn · Mallinckrodt Pharmaceuticals Ireland Limited
- 🇪🇺 Evarrest Withdrawn · Omrix Biopharmaceuticals N. V.
Follow Veraseal
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.